• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺结节伴有非诊断性细胞学结果:基于 2015 年美国甲状腺协会指南的超声模式随访管理。

Thyroid Nodules With Nondiagnostic Cytologic Results: Follow-Up Management Using Ultrasound Patterns Based on the 2015 American Thyroid Association Guidelines.

机构信息

1 Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.

出版信息

AJR Am J Roentgenol. 2018 Feb;210(2):412-417. doi: 10.2214/AJR.17.18532. Epub 2017 Nov 1.

DOI:10.2214/AJR.17.18532
PMID:29091005
Abstract

OBJECTIVE

The purpose of this study was to evaluate the malignancy rate of nodules with nondiagnostic cytologic results based on the American Thyroid Association (ATA) ultrasound (US) patterns and to suggest management guidelines for these nodules.

MATERIALS AND METHODS

From January 2013 to December 2014, 441 nodules (≥ 1 cm) were found in 437 patients with nondiagnostic results of ultrasound (US)-guided fine-needle aspiration biopsy (nondiagnostic nodules). A total of 191 nodules that were cytopathologically confirmed or were smaller (> 3 mm) at follow-up US were enrolled. The US findings of each nodule were reviewed. One radiologist classified the nodules into the following five categories according to the 2015 ATA guidelines: high, intermediate, low, and very low suspicion for malignancy and benign. The reference standard was histopathologic confirmation. Nodules that were smaller at follow-up US were considered benign. The malignancy rate of each category was calculated.

RESULTS

Among a total 191 nodules, 20 (10.5%) were malignant. Solid composition, marked hypoechogenicity, microlobulated or irregular margins, microcalcifications, and taller-than-wide shape were more frequently seen in malignant nodules (all p < 0.001). The malignancy rate of nodules with very low suspicion of malignancy was 0% (0/58); low, 0% (0/45); intermediate, 10.3% (6/58); and high, 46.7% (14/30) (p < 0.001).

CONCLUSION

When US findings of thyroid nodules are assessed according to the 2015 ATA guidelines, nondiagnostic thyroid nodules with very-low- or low-suspicion US patterns can be followed up with US. Nondiagnostic nodules with intermediate or highly suspicious US patterns should be evaluated with repeat US-guided fine-needle aspiration biopsy.

摘要

目的

本研究旨在评估基于美国甲状腺协会(ATA)超声(US)模式的非诊断性细胞学结果结节的恶性率,并为这些结节提出管理指南。

材料与方法

2013 年 1 月至 2014 年 12 月,对 437 例超声引导下细针抽吸活检结果为非诊断性(非诊断性结节)的患者的 441 个结节(≥1cm)进行了研究。共纳入 191 个经细胞病理学证实或随访超声(US)较大(>3mm)的结节。回顾每个结节的 US 结果。一名放射科医生根据 2015 年 ATA 指南将结节分为以下五类:高度、中度、低度、非常低度恶性和良性。参考标准为组织病理学证实。随访 US 较小的结节被认为是良性的。计算每个类别的恶性率。

结果

在总共 191 个结节中,有 20 个(10.5%)为恶性。实性成分、明显低回声、微分叶或不规则边缘、微钙化和高宽比是恶性结节更常见的特征(均 p<0.001)。非常低度可疑恶性的结节恶性率为 0%(0/58);低度为 0%(0/45);中度为 10.3%(6/58);高度为 46.7%(14/30)(p<0.001)。

结论

当根据 2015 年 ATA 指南评估甲状腺结节的 US 结果时,具有非常低或低度可疑 US 模式的非诊断性甲状腺结节可以通过 US 进行随访。具有中度或高度可疑 US 模式的非诊断性结节应通过重复 US 引导下细针抽吸活检进行评估。

相似文献

1
Thyroid Nodules With Nondiagnostic Cytologic Results: Follow-Up Management Using Ultrasound Patterns Based on the 2015 American Thyroid Association Guidelines.甲状腺结节伴有非诊断性细胞学结果:基于 2015 年美国甲状腺协会指南的超声模式随访管理。
AJR Am J Roentgenol. 2018 Feb;210(2):412-417. doi: 10.2214/AJR.17.18532. Epub 2017 Nov 1.
2
Malignancy risk stratification in thyroid nodules with nondiagnostic results at cytologic examination: combination of thyroid imaging reporting and data system and the Bethesda System.甲状腺细针穿刺细胞学检查结果不明确的甲状腺结节恶性风险分层:甲状腺影像报告和数据系统与 Bethesda 系统的联合应用。
Radiology. 2015 Jan;274(1):287-95. doi: 10.1148/radiol.14140359. Epub 2014 Aug 18.
3
Validation of the 2015 American Thyroid Association Management Guidelines for Thyroid Nodules With Benign Cytologic Findings in the Era of the Bethesda System.验证 2015 年美国甲状腺协会甲状腺结节管理指南在 Bethesda 系统时代对良性细胞学发现的适用性。
AJR Am J Roentgenol. 2018 Mar;210(3):629-634. doi: 10.2214/AJR.17.18507. Epub 2018 Jan 11.
4
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.ACR TI-RADS 与 ATA US 评分有助于对具有不确定细胞学特征的甲状腺结节进行管理。
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
5
Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.超声引导下细针穿刺细胞学检查为良性的甲状腺结节的随访策略:贝塞斯达系统前后时代应用超声甲状腺结节管理指南的恶性肿瘤发生率。
Thyroid. 2019 Sep;29(9):1227-1236. doi: 10.1089/thy.2018.0769. Epub 2019 Aug 28.
6
Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.超声 K-TIRADS 分类与 2015 年 ATA 指南在甲状腺结节及滤泡性肿瘤良恶性危险分层中的诊断效能
AJR Am J Roentgenol. 2019 Aug;213(2):444-450. doi: 10.2214/AJR.18.20961. Epub 2019 Apr 30.
7
Malignancy Risk Stratification of Thyroid Nodules: Comparison between the Thyroid Imaging Reporting and Data System and the 2014 American Thyroid Association Management Guidelines.甲状腺结节恶性风险分层:甲状腺影像报告和数据系统与 2014 年美国甲状腺协会管理指南的比较。
Radiology. 2016 Mar;278(3):917-24. doi: 10.1148/radiol.2015150056. Epub 2015 Sep 8.
8
Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.美国甲状腺协会超声评估甲状腺结节细针抽吸术适应证的验证。
Thyroid. 2017 Aug;27(8):1077-1082. doi: 10.1089/thy.2016.0555. Epub 2017 Jul 18.
9
Ultrasound-guided thyroid nodule biopsy: outcomes and correlation with imaging features.超声引导下甲状腺结节活检:结果及其与影像学特征的相关性
Clin Imaging. 2015 Mar-Apr;39(2):200-6. doi: 10.1016/j.clinimag.2014.10.019. Epub 2014 Nov 7.
10
Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.甲状腺超声引导下细针穿刺细胞学检查结果:过去十年间不确定率呈上升趋势。
Otolaryngol Head Neck Surg. 2017 Apr;156(4):611-615. doi: 10.1177/0194599816688190. Epub 2017 Jan 24.

引用本文的文献

1
IS REPEAT FNAB NECESSARY FOR THYROID NODULES WITH ND / UNS CYTOLOGY?对于细针穿刺结果为不确定/不能确定的甲状腺结节,重复细针穿刺抽吸活检是否必要?
Acta Endocrinol (Buchar). 2022 Jan-Mar;18(1):127-133. doi: 10.4183/aeb.2022.127.
2
Assessment of diagnostic capacity and decision-making based on the 2015 American Thyroid Association ultrasound classification system.基于2015年美国甲状腺协会超声分类系统的诊断能力评估与决策制定
World J Methodol. 2022 May 20;12(3):148-163. doi: 10.5662/wjm.v12.i3.148.
3
Comparison of Four Ultrasonography-Based Risk Stratification Systems in Thyroid Nodules with Nondiagnostic/Unsatisfactory Cytology: A Real-World Study.
基于超声的四种风险分层系统在甲状腺结节非诊断性/不满意细胞学检查中的比较:一项真实世界研究
Cancers (Basel). 2021 Apr 18;13(8):1948. doi: 10.3390/cancers13081948.
4
The combination of ATA classification and FNA results can improve the diagnostic efficiency of malignant thyroid nodules.美国甲状腺协会(ATA)分类与细针穿刺活检(FNA)结果相结合可提高甲状腺恶性结节的诊断效率。
Endocr Connect. 2020 Sep;9(9):903-911. doi: 10.1530/EC-20-0303.
5
Contemporary Thyroid Nodule Evaluation and Management.当代甲状腺结节评估与管理。
J Clin Endocrinol Metab. 2020 Sep 1;105(9):2869-83. doi: 10.1210/clinem/dgaa322.